Impact of Peer Support on Diabetes in China
Not Applicable
- Conditions
- Glucose Metabolism DisordersMetabolic DiseasesEndocrine System DiseasesDiabetes
- Interventions
- Behavioral: peer supportOther: usual education lectures
- Registration Number
- NCT02119572
- Lead Sponsor
- Zhongda Hospital
- Brief Summary
The prevalence of diabetes has been growing rapidly in developing countries causing a devastating economic burden and increasing demands on healthcare systems. Therefore, there is an urgent need to find cost-effective and multi-faceted approach for diabetes care. Peer support models provide a potentially low-cost, flexible means that is complimentary to the current existing health care services. Trained peer leaders can become qualified extenders to a formal healthcare system, thereby, assisting with the education delivery and bolstering the efforts of the professional staff. To implement a culturally- specific peer support program and determine whether it is acceptable, cost-effective in China is important. This study aims to implement and evaluate biophysical and psychosocial outcomes of a peer support program and to explore it's feasibility and sustainability in China
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
- type 2 diabetes
- with voluntary participation and have signed the Patient Informed Consent Sheet
- reside in stable places during the intervention period
Exclusion Criteria
- Patients with reduced life expectancy and unstable mood or major psychiatric conditions
- suffering from cancer and have been receiving radiotherapy and/ or chemotherapy in the past half year
- enrolling in other research program at present
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description peer support peer support Patients are divided into small groups and assigned with peer leaders for twelve months according to their residence. Besides the same training and follow-ups as the control arm, patients from intervention groups are suggested and encouraged to take part in the group activities with the peer leaders per month. And if possible, casual activities (such as phone call, chatting, short message; physical exercise, group member family visiting，going to supermarket together, etc.)are also recommended peer support usual education lectures Patients are divided into small groups and assigned with peer leaders for twelve months according to their residence. Besides the same training and follow-ups as the control arm, patients from intervention groups are suggested and encouraged to take part in the group activities with the peer leaders per month. And if possible, casual activities (such as phone call, chatting, short message; physical exercise, group member family visiting，going to supermarket together, etc.)are also recommended usual education usual education lectures Patients attend the usual self-management education and communicate with the professionals every two months, getting the information on diabetes diet, exercise, glucose monitor, etc. besides that the group members should attend three follow ups at baseline,6 and 12 months.
- Primary Outcome Measures
Name Time Method Change from Baseline HbA1c at 6 months,12 months baselline,6months,12months
- Secondary Outcome Measures
Name Time Method Change from Baseline blood pressure at 6 months,12 months baseline,6 months,12months Change from Baseline months BMI at 6 months,12 months baseline,6 months,12months Change from Baseline months blood liquids at 6 months,12 months baseline,6 months,12months Change from Baseline months blood glucose at 6 months,12 months baseline,6 months,12months Change from baseline in diabetes self-care activities scales at 6 months,12months baseline,6 months,12months Change from baseline in depression scales at 6 months,12months baseline,6 months,12months Change from baseline in medication adherence scales at 6 months,12months baseline,6 months,12months Change from baseline in quality of life scales at 6 months,12months baseline,6 months,12months Change from baseline in diabetes self-efficacy scales at 6 months,12months baseline,6 months,12months Change from baseline in diabetes knowledge scales at 6 months,12months baseline,6 months, 12 months Change from baseline in positive and negative affectivity at 6 months,12months baseline, 6 months,12months Change from baseline in events of hypoglycemia at 6 months,12months baseline,6 months,12months Change from baseline advanced glycation end products at 6 months,12months baseline ,6 months,12months cost baseline,6 months,12 months
Trial Locations
- Locations (1)
Liuhe
🇨🇳Nanjing, Jiangsu, China